Meyka Pro banner
Bausch + Lomb Corporation

Bausch + Lomb Corporation Fundamental Analysis (NYSE: BLCO)

BLCONYSE
HealthcareMedical - Instruments & Supplies
$17.20
$0.25(1.43%)
U.S. Market opens in 14h 39m

Bausch + Lomb Corporation Fundamental Analysis (NYSE: BLCO)

Bausch + Lomb Corporation (NYSE: BLCO) shows moderate financial fundamentals with a PE ratio of -35.79, profit margin of -3.21%, and ROE of -2.67%. The company generates $5.3B in annual revenue with moderate year-over-year growth of 6.47%.

Key Strengths

PEG Ratio-1.44
Current Ratio1.55

Areas of Concern

ROE-2.67%
Operating Margin7.14%
We analyze BLCO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 21.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
21.7/100

We analyze BLCO's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLCO struggles to generate sufficient returns from assets.

ROA > 10%
-1.23%

Valuation Score

Excellent

BLCO trades at attractive valuation levels.

PE < 25
-35.79
PEG Ratio < 2
-1.44

Growth Score

Moderate

BLCO shows steady but slowing expansion.

Revenue Growth > 5%
6.47%
EPS Growth > 10%
-13.33%

Financial Health Score

Excellent

BLCO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.80
Current Ratio > 1
1.55

Profitability Score

Weak

BLCO struggles to sustain strong margins.

ROE > 15%
-266.85%
Net Margin ≥ 15%
-3.21%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLCO Expensive or Cheap?

P/E Ratio

BLCO trades at -35.79 times earnings. This suggests potential undervaluation.

-35.79

PEG Ratio

When adjusting for growth, BLCO's PEG of -1.44 indicates potential undervaluation.

-1.44

Price to Book

The market values Bausch + Lomb Corporation at 0.96 times its book value. This may indicate undervaluation.

0.96

EV/EBITDA

Enterprise value stands at 1.84 times EBITDA. This is generally considered low.

1.84

How Well Does BLCO Make Money?

Net Profit Margin

For every $100 in sales, Bausch + Lomb Corporation keeps $-3.21 as profit after all expenses.

-3.21%

Operating Margin

Core operations generate 7.14 in profit for every $100 in revenue, before interest and taxes.

7.14%

ROE

Management delivers $-2.67 in profit for every $100 of shareholder equity.

-2.67%

ROA

Bausch + Lomb Corporation generates $-1.23 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.23%

Following the Money - Real Cash Generation

Operating Cash Flow

Bausch + Lomb Corporation generates limited operating cash flow of $458.48M, signaling weaker underlying cash strength.

$458.48M

Free Cash Flow

Bausch + Lomb Corporation generates weak or negative free cash flow of $140.35M, restricting financial flexibility.

$140.35M

FCF Per Share

Each share generates $0.39 in free cash annually.

$0.39

FCF Yield

BLCO converts 2.28% of its market value into free cash.

2.28%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-35.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.44

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.15

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.80

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.55

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.03

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How BLCO Stacks Against Its Sector Peers

MetricBLCO ValueSector AveragePerformance
P/E Ratio-35.7931.19 Better (Cheaper)
ROE-2.67%447.00% Weak
Net Margin-3.21%21601.00% Weak
Debt/Equity0.800.54 Weak (High Leverage)
Current Ratio1.555.66 Neutral
ROA-1.23%-50.00% (disorted) Weak

BLCO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bausch + Lomb Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

47.90%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1878.52%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-46.37%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ